Souders Financial Advisors Novo Nordisk A S Transaction History

Souders Financial Advisors

$639 Million
Q2 2024

A detailed history of Souders Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Souders Financial Advisors holds 39,696 shares of NVO stock, worth $5.52 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

39,696

Previous 39,466 0.58%

Holding current value

$5.52 Million

Previous $5.07 Million 11.82%

% of portfolio

0.89%

Previous 0.83%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 28, 2024	BUY	$122.71 - $146.91 $28,223 - $33,789	230 Added 0.58%	39,696 $5.67 Million
Q1 2024 May 08, 2024	SELL	$102.11 - $135.92 $252,518 - $336,130	-2,473 Reduced 5.9%	39,466 $5.07 Million
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $51,263 - $61,582	-584 Reduced 1.37%	41,939 $4.34 Million
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $1.61 Million - $3.54 Million	17,746 Added 71.62%	42,523 $3.87 Million
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $356,258 - $394,332	-2,284 Reduced 8.44%	24,777 $4.01 Million
Q1 2023 May 09, 2023	SELL	$132.34 - $159.14 $22,100 - $26,576	-167 Reduced 0.61%	27,061 $4.31 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $10,665 - $14,074	104 Added 0.38%	27,228 $3.68 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $507,080 - $622,301	-5,322 Reduced 16.4%	27,124 $2.7 Million
Q2 2022 Aug 05, 2022	BUY	$103.24 - $121.81 $23,332 - $27,529	226 Added 0.7%	32,446 $3.62 Million
Q1 2022 May 04, 2022	BUY	$93.1 - $112.54 $12,661 - $15,305	136 Added 0.42%	32,220 $3.58 Million
Q4 2021 Feb 04, 2022	SELL	$95.88 - $117.08 $74,211 - $90,619	-774 Reduced 2.36%	32,084 $3.59 Million
Q3 2021 Nov 03, 2021	BUY	$84.42 - $106.62 $43,054 - $54,376	510 Added 1.58%	32,858 $3.16 Million
Q2 2021 Aug 09, 2021	BUY	$67.66 - $84.76 $41,001 - $51,364	606 Added 1.91%	32,348 $2.71 Million
Q1 2021 May 13, 2021	BUY	$67.06 - $75.82 $75,107 - $84,918	1,120 Added 3.66%	31,742 $2.14 Million
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $38,461 - $44,427	602 Added 2.01%	30,622 $2.14 Million
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $75,536 - $83,280	1,186 Added 4.11%	30,020 $2.03 Million
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $813,647 - $944,298	13,899 Added 93.06%	28,834 $1.89 Million
Q1 2020 May 12, 2020	BUY	$49.46 - $64.78 $738,685 - $967,489	14,935 New	14,935 $899,000

Others Institutions Holding NVO

# of Institutions

1,988

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $314B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Souders Financial Advisors with notifications on news.

Account

Souders Financial Advisors Novo Nordisk A S Transaction History